A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

As Sanofi prepares to halt U.S. marketing of its dengue vaccine in 2026, locally acquired infections in the country are ...

The funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with ...

Sanofi CEO Paul Hudson joins 'Squawk Box' to discuss the company's quarterly earnings results, drug pipeline outlook, the ...

French pharamceutical giant Sanofi has confirmed plans to sell a controlling stake in its over-the-counter unit to a US ...

A health-care buyout has been sealed by an American firm against a rival Gallic offer. That’s despite the asset being a ...

Sanofi SA (NASDAQ:SNY) and private equity Clayton Dubilier & Rice (CD&R) have finally entered into exclusive negotiations to ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than ...

US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France.

Sanofi to present dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria at ACAAI: Paris Saturday, October 26, 2024, 12:00 Hrs [IST] Positive data from the ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...